AU7994694A - Controlled release oral delivery system containing oxybutynin - Google Patents

Controlled release oral delivery system containing oxybutynin

Info

Publication number
AU7994694A
AU7994694A AU79946/94A AU7994694A AU7994694A AU 7994694 A AU7994694 A AU 7994694A AU 79946/94 A AU79946/94 A AU 79946/94A AU 7994694 A AU7994694 A AU 7994694A AU 7994694 A AU7994694 A AU 7994694A
Authority
AU
Australia
Prior art keywords
delivery system
controlled release
system containing
oral delivery
release oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79946/94A
Inventor
Pertti Rantala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Oy
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8556592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU7994694(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of AU7994694A publication Critical patent/AU7994694A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU79946/94A 1994-10-21 1994-10-21 Controlled release oral delivery system containing oxybutynin Abandoned AU7994694A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FI1994/000474 WO1996012477A1 (en) 1994-10-21 1994-10-21 Controlled release oral delivery system containing oxybutynin

Publications (1)

Publication Number Publication Date
AU7994694A true AU7994694A (en) 1996-05-15

Family

ID=8556592

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79946/94A Abandoned AU7994694A (en) 1994-10-21 1994-10-21 Controlled release oral delivery system containing oxybutynin

Country Status (2)

Country Link
AU (1) AU7994694A (en)
WO (1) WO1996012477A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262115B1 (en) 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US6171298B1 (en) 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
AU3799997A (en) * 1996-07-09 1998-02-02 Sepracor, Inc. Dextrorotatory isomers of oxybutynin and desethyloxybutynin in the treatment of gastrointestinal hyperactivity
AR018321A1 (en) * 1998-03-26 2001-11-14 Alza Corp A DOSAGE FORM OF PROLONGED LIBERATION THAT INCLUDES OXIBUTININE AND THE USES OF OXIBUTININE AND THE DOSAGE FORM OF PROLONGED LIBERATION.
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
NZ504618A (en) * 1998-08-27 2002-09-27 Pharmacia & Upjohn Ab Controlled release therapeutic formulation for administering tolterodine maintaining a constant serum level
AU1256399A (en) * 1998-10-07 2000-04-26 Alza Corporation Controlled release dosage from comprising oxybutynin
WO2001034139A1 (en) 1999-11-11 2001-05-17 Pharmacia Ab Pharmaceutical formulation containing tolterodine and its use
US6248359B1 (en) 2000-01-05 2001-06-19 Laboratorios Phoenix U.S.A., Inc. Multi-tablet oxybutynin system for treating incontinence
DE10149674A1 (en) 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orally administered composition for sustained release of propiverine, useful for treatment of hypertonic bladder disorders, especially by once-daily administration
US8329217B2 (en) 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
US20030185882A1 (en) 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
DE10315917A1 (en) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Highly pure bases of 3,3-diphenylpropylamine monoesters
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
US5368861A (en) * 1989-10-26 1994-11-29 Nippon Shinyaku Co., Ltd. Gastric preparation with sustained release
US5399359A (en) * 1994-03-04 1995-03-21 Edward Mendell Co., Inc. Controlled release oxybutynin formulations

Also Published As

Publication number Publication date
WO1996012477A1 (en) 1996-05-02

Similar Documents

Publication Publication Date Title
AU2827095A (en) Controlled release oral drug delivery system
AU1356597A (en) Automatic medicament dispenser system
AU3050892A (en) Delivery system
AUPM897594A0 (en) Controlled release container
AU4129396A (en) Diketopiperazine-based delivery systems
AU4175896A (en) Braking system
AU1966892A (en) Cosmetic delivery system
AU2662095A (en) Improved wheelchair back system
AU5676596A (en) Oral insulin delivery
AU6558296A (en) Buccal delivery system for therapeutic agents
AU1806895A (en) Controlled release composition
AU2816297A (en) Recipient-dosage delivery system
AU1967792A (en) Cosmetic delivery system
AU7093396A (en) Medicament conversion system
AU7994694A (en) Controlled release oral delivery system containing oxybutynin
AU1709197A (en) Time release delivery system
AU2275695A (en) Dental restoration holder system
AU3362595A (en) Nozzle system
AU5401796A (en) Solid delivery form for oral use
AU2826695A (en) Tablet dispensing system
AU5359394A (en) Earplug dispenser system
AU2195292A (en) Dispenser system
AU5347996A (en) Preparation for oral administration
AU3991695A (en) Ranging system
AU7164996A (en) Constituent delivery system